HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viral Encephalitis

Inflammation of brain parenchymal tissue as a result of viral infection. Encephalitis may occur as primary or secondary manifestation of TOGAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; BUNYAVIRIDAE INFECTIONS; PICORNAVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RETROVIRIDAE INFECTIONS; and ARENAVIRIDAE INFECTIONS.
Also Known As:
Encephalitis, Viral; Encephalomyelitis, Viral Infectious; Viral Infectious Encephalomyelitis; Encephalomyelitis, Infectious, Viral; Infectious Encephalomyelitis, Viral
Networked: 471 relevant articles (23 outcomes, 34 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infections
2. Seizures (Absence Seizure)
3. Encephalitis (Encephalitis, Rasmussen)
4. Neoplasms (Cancer)
5. Status Epilepticus (Complex Partial Status Epilepticus)

Experts

1. Solomon, Tom: 7 articles (01/2018 - 06/2003)
2. Kalinke, Ulrich: 6 articles (01/2022 - 01/2018)
3. Tyler, Kenneth L: 6 articles (01/2019 - 04/2005)
4. Klein, Robyn S: 5 articles (01/2022 - 11/2018)
5. Ghita, Luca: 5 articles (10/2021 - 01/2018)
6. Basu, Anirban: 5 articles (03/2021 - 02/2007)
7. Bergmann, Cornelia C: 5 articles (10/2013 - 04/2005)
8. Stohlman, Stephen A: 5 articles (10/2013 - 04/2005)
9. Waltl, Inken: 4 articles (01/2022 - 01/2018)
10. Chhatbar, Chintan: 4 articles (11/2018 - 01/2018)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Viral Encephalitis:
1. Antiviral Agents (Antivirals)IBA
2. Acyclovir (Aciclovir)FDA LinkGeneric
3. Proteins (Proteins, Gene)FDA Link
4. Naloxone (Narcan)FDA LinkGeneric
5. Intravenous Immunoglobulins (IVIG)FDA Link
6. Adrenal Cortex Hormones (Corticosteroids)IBA
7. VaccinesIBA
8. Minocycline (Cyclops)FDA LinkGeneric
9. Neutralizing AntibodiesIBA
10. NeopterinIBA

Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Continuous Renal Replacement Therapy
4. Immunomodulation
5. Secondary Prevention